Onderneming Momenta Pharmaceuticals, Inc.
Aandelen
MNTA
US60877T1007
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Lee
PSD | President | - | - |
Patty Eisenhaur
IRC | Investor Relations Contact | - | - |
Comptroller/Controller/Auditor | - | 01-04-19 | |
Ian D. Fier
PRN | Corporate Officer/Principal | - | 01-10-02 |
Human Resources Officer | - | 01-10-07 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | - | 01-10-20 | |
Director/Board Member | - | 01-10-20 | |
Jonathan Bryant
BRD | Director/Board Member | - | 01-10-20 |
David Lee
PSD | President | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 119 533 224 | 118 124 353 ( 98,82 %) | 568 000 ( 0,4752 %) | 98,82 % |
Bedrijfsgegevens
Momenta Pharmaceuticals, Inc.
1125 Trenton-harbourton Road
08560, Titusville
+617 491 9700
http://www.momentapharma.com![Adres Momenta Pharmaceuticals, Inc.(MNTA)](https://cdn.zonebourse.com/static/address/10057.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,13% | 122 mld. | |
+19,65% | 115 mld. | |
+21,22% | 26,64 mld. | |
-23,84% | 19,91 mld. | |
-17,47% | 16,32 mld. | |
-45,95% | 15,52 mld. | |
-19,28% | 15,49 mld. | |
+63,81% | 14,83 mld. | |
+1,94% | 13,67 mld. |